The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of single agent amrubicin (A) in patients (pts) with previously treated advanced thymic malignancies (TM).
 
Heather A. Wakelee
Honoraria - Biocon; Peregrine Pharmaceuticals
Consulting or Advisory Role - Peregrine Pharmaceuticals
Research Funding - Agennix (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - Biocon; Peregrine Pharmaceuticals
 
Sukhmani Kaur Padda
No Relationships to Disclose
 
Matthew Burns
No Relationships to Disclose
 
Aaron John Spittler
No Relationships to Disclose
 
Jonathan Riess
Honoraria - Roche/Genentech
Research Funding - Millennium; Onconova Therapeutics
Travel, Accommodations, Expenses - Roche/Genentech
 
Melanie San Pedro-Salcedo
No Relationships to Disclose
 
Kavitha Ramchandran
Consulting or Advisory Role - GTX
Travel, Accommodations, Expenses - GTX
 
Matthew A. Gubens
Consulting or Advisory Role - Celgene; Genentech/Roche; Pfizer
Research Funding - Abbvie; Celgene; Genentech/Roche; Merck; Novartis
 
Joel W. Neal
Consulting or Advisory Role - Clovis Oncology
Research Funding - ArQule; Boehringer Ingelheim; Exelixis; Genentech/Roche; Merck; Nektar; Novartis
 
Patrick J. Loehrer
Research Funding - Celgene (Inst); ImClone Systems (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - US PPA/61/499,988 Gene Expression Analysis of Thymic Neoplasms Inventors: Sunil Badve, Yesim Gokmen-Polar, Patrick Loehrer (Inst)